OHRI sets course to advance translational health research

March 8, 2011

The Ottawa Hospital Research Institute (OHRI) has released three-year strategic directions which are designed to enhance the Institute’s leadership in translating health research into benefits for patients and society.

“Over the last few years, there have been many examples of research at OHRI improving care for patients at The Ottawa Hospital and around the world,” said Dr. Duncan Stewart, CEO and Scientific Director of OHRI, Vice President of Research at The Ottawa Hospital and Professor of Medicine at the University of Ottawa. “Our new strategic directions are designed to take us even further, and ensure that our researchers have the tools and support they need to take their discoveries from bench to bedside and from evidence to practice.”

The Ottawa Hospital Research Institute is the research arm of The Ottawa Hospital and an affiliated institute of the University of Ottawa. With more than 1,500 scientists, clinical investigators, trainees and staff, and total revenues in excess of $100 million, OHRI is one of the foremost Canadian hospital-based research institutes.

Download OHRI’s Strategic Directions.